Meta-Analysis in sponsored studies MEA112997, MEA115588, and MEA115575 and a proof of concept investigator sponsored study CRT110184 of Mepolizumab in Severe Asthma

Update Il y a 5 ans
Reference: GSK204664

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The analyses described in this document are being conducted to generate estimates of the effect of mepolizumab on exacerbations requiring hospitalisation/ED visits and hospitalisation alone which are observed at relatively low frequencies in individual studies. Exacerbations requiring hospitalization/ED visits are serious for patients, but are difficult to study in a single randomised controlled clinical trial as they occur relatively infrequently. The meta-analysis will also investigate the relationship between efficacy endpoints and blood eosinophils providing further information on the relationship between baseline blood eosinophils thresholds and the effects of treatment with mepolizumab.


Inclusion criteria

  • Asthma

Links